Lucienne brings her diverse experience in medicine, science, venture capital and technology to bear in leading Rimidi's strategy and vision. Motivated by the belief that we can all do so much better as individuals, an industry and society, Lucienne left clinical medicine to join the ranks of healthcare entrepreneurs who are revolutionizing an industry. Internship UPMC. MD/PhD Emory University. BA Physics Middlebury. NSA, CIA, Monarch Partners.

Chris has over twenty years leading software development efforts for organizations in industries such as healthcare, finance, oil and gas. Chris currently oversees the design and development of Rimidi’s product line. He has provided technical guidance to organizations such as the Centers for Disease Control and Prevention, ACS, Bridgestone, NPR, Halliburton, and Cessna.

Bill is an expert in corporate governance, special investigations, and crisis management ethics. He serves as a member of the Board of Albemarle (ALB) and AFC Enterprises (AFCE). He is chair of the Advisory Board to the Conference Board's Governance Center and Gen'l Counsel and Secretary of the East West Institute and former Gen'l Counsel of Monsanto Company and the US Olympic Committee. Former President of the American Bar Association. JD/MBA.

Jennifer has fifteen years of experience advising companies about legal and regulatory risks and guiding them in business decisions. She oversees the Company’s legal and regulatory matters and serves as the Company’s compliance officer and HIPAA privacy and security officer. Jennifer practiced at Sutherland Asbill & Brennan before joining Rimidi.

Josh Claman is an experienced global executive with over 25 years leading technology businesses - several senior executive positions at Dell, including developing Dell’s European Healthcare business, to President of ReachLocal, one of the largest advertising technology companies in the US, and serving as the Chief Business Officer of Stratasys, a leader in 3D printing in the medical field. Josh is a strong advocate for the promise of technology.